review Open AccessTop 10% cited
Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review
BMC Cancer · 2013 · Vol. 13(1) · pp. 158–158
Syed Hasan Raza Jafri✉(Louisiana State University)Runhua Shi(Louisiana State University)Glenn Mills(Louisiana State University)
Abstract
ALI (<18) at diagnosis is an independent marker of poor outcome in patients with advanced NSCLC.
Inflammatory Biomarkers in Disease PrognosisLung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentMedicineSurgical oncologyLung cancerOncologyCancerInternal medicineRetrospective cohort studyLungPathology
MeSH terms
AdenocarcinomaAdultAgedAged, 80 and overCarcinoma, Non-Small-Cell LungFemaleHumansInflammationLung NeoplasmsMaleMiddle AgedMutationNeoplasm MetastasisNeoplasm StagingPrognosis
Citations
372
FWCI
6.59
field-weighted impact
References
19
Percentile
98%
vs. same field & year
Citations per year
Cited by
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
JNCI Journal of the National Cancer Institute · 2014 · 3,162 citations
References
Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer
British Journal of Cancer · 2003 · 771 citations
Inflammation and cancer: An ancient link with novel potentials
International Journal of Cancer · 2007 · 1,080 citations
Neutrophil/lymphocyte ratio and its association with survival after complete resection in non–small cell lung cancer
Journal of Thoracic and Cardiovascular Surgery · 2008 · 568 citations
Hallmarks of Cancer: The Next Generation
Cell · 2011 · 65,668 citations
Cancer-related inflammation
Nature · 2008 · 11,167 citations
Cancer statistics, 2012
CA A Cancer Journal for Clinicians · 2012 · 10,709 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.